Applied Economics, published by Routledge Journals, Taylor & Francis Ltd, is a revered platform in the field of Economics and Econometrics. Since its inception in 1969, the journal has maintained its commitment to disseminating high-quality research, covering a wide range of topics within applied economics that are critical for understanding and addressing real-world economic issues. With a notable Q2 ranking in Economics and Econometrics and a strong standing in the 67th percentile of Scopus rankings, it serves as an essential resource for researchers, professionals, and students alike, providing insights that bridge theoretical frameworks and practical applications. While the journal is not an Open Access platform, it continues to foster academic discourse and innovation within the economics community, contributing to the ongoing development of evidence-based policies and practices. Its accessibility and robust editorial standards ensure that the latest findings and methodologies reach an engaged audience, further solidifying its reputation as a key publication in the field.

HEALTH SERVICES RESEARCH, published by Wiley, is a premier journal focused on advancing the field of health policy and services research. With an ISSN of 0017-9124 and an impressive E-ISSN of 1475-6773, this esteemed publication has been at the forefront of health services inquiry since its inception in 1966. Recognized as a Q1 journal in Health Policy for 2023, it ranks #80 out of 310 in Scopus, placing it in the 74th percentile, underlining its significant influence in the field. The journal caters to a global audience of researchers, practitioners, and students by providing a platform for rigorous empirical studies and critical reviews that aim to improve health care delivery and policy outcomes. Although it does not offer open access, the comprehensive articles and insights published within its pages are essential for anyone seeking to understand and influence health systems. With its convergence towards the year 2024, HEALTH SERVICES RESEARCH continues to be a vital resource for those dedicated to enhancing healthcare effectiveness and accessibility.

JOURNAL OF PUBLIC ECONOMICS is a leading academic journal published by ELSEVIER SCIENCE SA, dedicated to the field of public economics, which encompasses a broad range of topics including taxation, government expenditure, and the effects of public policies on the economy. With an impressive impact factor reflected by its prestigious Q1 category rankings in both Economics and Finance, this journal is recognized as a vital resource for researchers and practitioners alike. Its robust Scopus rankings place it in the top percentile, with Finance ranked #8 out of 317 and Economics ranked #19 out of 716, demonstrating its influential role in advancing knowledge and fostering discourse within its discipline. Covering the period from 1972 through 2024, the journal publishes original research and insightful reviews that encourage evidence-based policy-making, making it an essential read for those seeking to deepen their understanding of the intersections between economics and public policy. Please note that the journal operates under a subscription model of access, ensuring high-quality content is readily available to its readership.

Pharmacoeconomics-Open, an esteemed journal published by SPRINGER INT PUBL AG, is a vital resource for scholars and practitioners in the fields of health policy and pharmacology. Since its transition to an Open Access platform in 2017, the journal has aimed to democratize access to valuable research, fostering innovation and collaboration globally. With notable rankings in the 2023 Scopus indices—including Q2 in Health Policy and both categories of Pharmacology—Pharmacoeconomics-Open engages with pressing issues in health economics, providing insights into cost-effectiveness analyses and healthcare decision-making. The journal’s commitment to high-quality, peer-reviewed articles ensures that it remains a significant player in advancing knowledge and understanding within its disciplines, serving as an essential forum for researchers, policymakers, and students alike.

Economics & Human Biology, published by Elsevier, is a prestigious journal that serves as an interdisciplinary platform at the intersection of economics and health sciences. With ISSN 1570-677X and E-ISSN 1873-6130, this journal analyzes the implications of economic factors on human health and biological outcomes. As a recognized leader in its field, it has earned a remarkable Q1 ranking in both the Economics, Econometrics and Finance (miscellaneous) and Health (social science) categories for 2023, reflecting its significant impact within the academic community, as evidenced by its Scopus rank of 88 out of 371 and a 76th percentile ranking in Health social sciences. Highlighting key issues such as health disparities, economic policy impacts on health, and the biological determinants of economic behavior, the journal encourages innovative research that bridges these critical domains. Researchers, professionals, and students seeking to contribute to or stay informed on emerging trends in health economics will find this journal an invaluable resource. Explore the latest findings and engage with a community dedicated to advancing our understanding of the interplay between economics and human biology.

Global & Regional Health Technology Assessment (ISSN: 2284-2403; E-ISSN: 2283-5733) is an esteemed open-access journal published by ABOUTSCIENCE SRL, dedicated to the dissemination of research in the field of health technology assessment on a global and regional scale. Since its inception in 2014, this journal has focused on the critical evaluation of health technologies, providing invaluable insights into their efficacy, cost-effectiveness, and impact on healthcare systems. With an increasing emphasis on public health and policy implications, the journal encourages interdisciplinary research that bridges gaps between technological innovations and health outcomes. Despite its relatively recent establishment, it has made significant inroads with Scopus rankings reflecting the growing importance of health technology assessment in global health discourse. The journal welcomes contributions from researchers, professionals, and students, inviting them to engage in discussions that shape the future of health technology, with the aim of informing stakeholders and policymakers worldwide.

PHARMACOECONOMICS, published by ADIS INT LTD, is a prestigious international journal dedicated to disseminating research in the fields of health policy, pharmacology, and public health. With an impressive impact factor and a solid Q1 ranking across its relevant categories, this journal plays a crucial role in shaping policy decisions, optimizing health resources, and enhancing pharmacoeconomic evaluations globally. The journal not only targets researchers and professionals but also serves as an invaluable resource for students striving to understand the economic implications of pharmaceutical care. Operating since 1992 and continuously evolving through 2024, PHARMACOECONOMICS invites contributions that address the complexities of drug expenditure, health outcomes, and public health implications, thereby fostering informed decision-making in healthcare systems. Readers can explore cutting-edge studies and analyses aimed at balancing cost-effectiveness with clinical effectiveness, making this journal a cornerstone for stakeholders invested in the future of health economics.

The American Journal of Health Economics is a premier academic publication dedicated to advancing the understanding of the economic aspects of health and healthcare. Published by the University of Chicago Press, this journal has established itself as a vital resource for researchers, policymakers, and health professionals since its convergence in 2015. With an impressive Q1 ranking in key categories—including Economics, Health Policy, and Public Health—and a solid reputation in the academic community, it ranks in the top 20% for Economics and Health Policy in the Scopus database. The journal seeks to publish high-quality, peer-reviewed articles that contribute to the discourse on health economics, addressing critical issues like health disparities, policy evaluation, and the efficiency of healthcare systems. Although it does not offer open access, subscribers can access groundbreaking research that shapes health economic strategies and practices. As a trusted source in its field, the American Journal of Health Economics plays a crucial role in fostering evidence-based decision-making and enhancing the impact of economic research in healthcare.

The European Journal of Health Economics, published by SPRINGER, is a premier interdisciplinary journal dedicated to advancing research in the intersection of health policy and economic theory. With an impressive impact factor and consistently ranked in the Q1 category in both Economics and Health Policy (2023), this journal serves as a vital platform for disseminating innovative research findings and practical insights relevant to today's healthcare challenges. Covering a broad spectrum of topics, from health care financing and economic evaluation to policy analysis, the journal aims to foster dialogue among academics, policymakers, and practitioners alike. Published continuously from 2002 to 2024, the European Journal of Health Economics holds its rank within the top 12% of Economics and Finance journals and the top 16% in Medicine. Researchers and students looking to stay abreast of the latest trends and methodologies in health economics will find this journal an invaluable resource.

HEALTH ECONOMICS is a premier academic journal published by Wiley, dedicated to advancing the field of health economics. With an ISSN of 1057-9230, this journal has been a vital resource since its inception in 1992, and continues to contribute significantly to the academic landscape as it extends its cover to 2024. With a distinguished ranking of Q1 in Health Policy for 2023, it showcases cutting-edge research and theoretical advancements that inform health policy and economic decision-making globally. The journal features rigorous peer-reviewed articles that address a diverse range of topics within health economics, making it an essential platform for researchers, financial analysts, policymakers, and students alike. Although not an Open Access journal, it strives to ensure accessibility of critical insights for a broad audience, further enhancing its influence within the health economics community.